Explore it now
26th Annual ESGO 2025 Congress
Discover it Now!
ESGO took a pivotal step toward shaping the future of our field. All ESGO accredited centres in Europe and beyond were invited to join forces, forming the ESGO Consortium of Accredited Centres and sharing real-world clinical data through the ESGO Database platform. Out of those invited, 85 centres signed the Framework Agreement, strengthening scientific collaboration.
The goal of the ESGO Database is to conduct joint clinical research, including the validation of ESGO quality indicators (QI), identification of new QIs, analysis of guidelines adherence, and generation of real-world data in gynaecological oncology.
We are proud to announce that we have successfully closed the pilot project, 'Validation of the ESGO Quality Indicators in Advanced Ovarian Cancer Surgery,' collecting data from 12,000 patient records. The Database Core Group is currently working on a manuscript, and we anticipate the results will drive scientific progress, enhance quality assurance, and improve patient care in gynaecological oncology.
The findings will also continue to serve as a powerful tool for advocating centralization and subspecialty training, ultimately enhancing patient care.
Looking ahead, ESGO plans to expand the use of this data for future research, including new studies on endometrial cancer surgery. Additionally, there is also a vision to integrate the ESGO Database with ESGO's accreditation process.
Is your center ESGO Accredited? Would you like to be part of this pan-European and beyond vision and help advance care for women with gynecological cancer?
Don't hesitate; reach out to us via database@esgo.org and join the ESGO Consortium!
We are proud to say that to date, 85 centers from around the world have signed the Framework agreement and joined us in this collective effort!
The ESGO is now opening the first call for proposals for ovarian cancer studies within the ESGO database. This initiative aims to utilize existing data in the ESGO Database to address critical clinical questions related to advanced stage and recurrent ovarian cancer.
ESGO encourages ESGO Consortium members who have contributed with their centres data to the pilot project to submit study proposals that leverage the existing comprehensive data points (collected in the pilot study „Validation of the ESGO Quality Indicators in Advanced Ovarian Cancer Surgery“) within the ESGO Database to advance the understanding and treatment of ovarian cancer.
Eligible ESGO Consortium members can submit their initial proposals by September 15th, 2024. The Scientific Evaluation Committee (SEC) will review these submissions and projects with the highest scores will be invited to submit full proposals by November 29th, 2024. The selected studies will be announced at the ESGO Congress in Rome in February 2025, with studies starting soon after.
Centers, whose proposals are selected, will lead the project in cooperation with the ESGO, nominate a Principal Investigator, and publish the result as first author. Details on the framework of cooperation between the ESGO Consortium of Accredited Centres and ESGO had been presented by Prof Concin and approved by the Consortium at the closed meetings adjunct to ESGO Istanbul and Barcelona congresses.
If your center is ESGO-accredited and you'd like to join the ESGO Consortium, or if you need more information about the project, please contact us at database@esgo.org !
If your centre is a member of the ESGO Consortium of Accredited Centres and participated in the data entry for the pilot project "Validation of ESGO Quality Indicators in Advanced Ovarian Cancer Surgery", congratulations—you are eligible to submit a study proposal on ovarian cancer research!
All eligible ESGO Consortium members should have received the submission instructions and all necessary information via email. In case you did not receive the email or need the instructions resent, please feel free to contact us at database@esgo.org, and we’ll be happy to guide you through the process.
Please note that we are currently only accepting proposals working with the existing data in the ESGO Database. The submission deadline for the short proposal is September 15th, 2024. The Scientific Evaluation Committee (SEC) will review these submissions and studies with the highest scores will be invited to submit full proposals by November 29th, 2024. The selected studies will be announced at the ESGO Congress in Rome in February 2025, with the projects starting soon after.
We look forward to receiving many proposals, so do not hesitate and submit yours!
Recently, ESGO has established the SEC (Scientific Evaluation Committee) for Ovarian Cancer, comprised of leading experts in gynecological oncology within the ESGO Consortium, who will rotate and are nominated for a period of 2 years. The SEC will rigorously evaluate each proposal based on predefined criteria and specific assessment scores. Their role ensures that the most promising and impactful studies are selected for further development.
Presenting our respected OC SEC members:
Need further information? Contact the ESGO Office
"We invest a lot in translational and clinical studies with new drugs but we sometimes forget that surgery is still the main cornerstone of our treatment. Registration and quality control are essential to improve care for our patients."
Prof. Toon Van GorpUniversity Hospital Leuven
"Lets all bring our patients together to improve the survival and outcome of patients with women cancers.We can only win if we fight together!"
Prof. Christina FotopoulouImperial College London
"Learning about the activities of other centers and sharing knowledge and experience is the main goal which I hope will bear fruit in the activities of the consortium."
Prof. Marius BidzinskiThe Maria Sklodowska-Curie Memorial Cancer Center
"The development of this database and network will have a lasting impact on the gynaecological oncology research in Europe. We are excited to be part of this."
Prof. Björn LampeFlorence-Nightingale Hospital, Dusseldorf
"Amazing idea and extraordinarily visionary in the future for our patients and also our medical environment. I am proud to be a part of the ESGO community."
Prof. Pawel KnappMedical University of Bialystok
ESGO Life-time award winner (2019)
ESGO Life-time award winner (2021)